Cinnamtannin B1

Cinnamtannin B1

SCHEMBL20801029

Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)OC(c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 3/20 1.00
PRKCG P05129 3/20 1.00
PRKCB P05771 3/20 1.00
PRKCA P17252 3/20 1.00
PRKCH P24723 3/20 1.00
PRKCI P41743 3/20 1.00
PRKCE Q02156 3/20 1.00
PRKCQ Q04759 3/20 1.00
PRKCZ Q05513 3/20 1.00
PRKCD Q05655 3/20 1.00
PRKD1 Q15139 3/20 1.00
VEGFA P15692 2/20 0.89
PGF P49763 2/20 0.89
PRKAA2 P54646 1/20 0.89
FLT1 P17948 1/20 0.81
PDE4D Q08499 1/20 0.76
MMP2 P08253 4/20 0.75
MMP9 P14780 4/20 0.75
SNCA P37840 3/20 0.73
HSD17B10 Q99714 3/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamtannin B1 SCHEMBL13284073 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL29564472 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL94430 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL16063172 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL14595057 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL20801024 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin D1 SCHEMBL20789227 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL20814412 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL20814634 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH
Cinnamtannin B1 SCHEMBL29376280 1.00 PRKD3 (1.00) PRKD3PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10478418-B2 Inhibited expression of PD-L1 and enhanced expression of PD-1 IN INGREDIENTS, INC. (US) 2019-11-19 US disclosed
US-20190076397-A1 Inhibited Expression of PD-L1 and Enhanced Expression of PD-1 GTS BIOTECH LLC 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10478418-B2 Inhibited expression of PD-L1 and enhanced expression of PD-1 PDCD1, CD274, PDCD1LG2 PRKD3 1270/4885PRKCG 3508/4885PRKCB 2739/4885
US-20190076397-A1 Inhibited Expression of PD-L1 and Enhanced Expression of PD-1 PDCD1, CD274, PDCD1LG2 PRKD3 1270/4885PRKCG 3508/4885PRKCB 2739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.